What question did this study set out to answer?

To explore the contributions of T.C. Merigan in the treatment of viral infections over his extensive career.

January 10, 2026Molecules0 citationsOpen Access

Pioneering Role of T.C. Merigan in the Treatment of Various Virus Infections

ECE. De ClercqRega Institute for Medical Research

Key Result

T.C. Merigan's research identified interferon as a potential therapeutic agent for various virus infections, including VZV, HSV, CMV, HBV, and HIV.

Key Points

To explore the contributions of T.C. Merigan in the treatment of viral infections over his extensive career.
Reviewed Prof. Dr. Merigan's research spanning from 1963 to present
Evaluated his discoveries related to interferon and its inducers
Analyzed his work on specific viral infections such as VZV, HSV, CMV, HBV, and HIV
Identified interferon as a potential therapeutic agent for various viral infections
Developed synthetic inducers like pyran copolymer to enhance interferon production
Demonstrated effective treatments for herpes virus infections, HBV, and HIV

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

The research of Prof. Dr. Thomas C. Merigan has spanned almost half a century. It started in 1963 with his interest in interferon (i). He then identified pyran copolymer as a synthetic polyanionic inducer of interferon (ii), and thereafter thiophosphate-substituted polyribonucleotides, i.e., poly r(s¯A-s¯U) (iii). He recognized the potential of interferon as a therapeutic agent for virus infections (iv), varicella-zoster virus (VZV) being the first case in point (v). His interest then shifted to the treatment of herpes virus herpes simplex virus (HSV) and cytomegalovirus (CMV) infections (vi) and hepatitis B virus (HBV) infections (vii), to end up with human immunodeficiency virus (HIV) infections (viii, ix, x). T.C. Merigan’s pioneering work on the treatment of so many pivotal virus infections deserves further in-depth clinical evaluation.

Ask AI

Helpful

Bookmark

View Full Paper